|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|
| Revenue | |||
| Operating expenses: | |||
| Research and development | |||
| Sales and marketing | |||
| Depreciation expense | |||
| General and administrative expenses | |||
| Write-down of intangible assets and equipment | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other (expense) income: | |||
| Interest expense | |||
| Other income | |||
| Total other expense | |||
| Loss before income taxes | |||
| Income tax expense | |||
| Net loss | |||
| Accrued dividends to Series A and Series B preferred stockholders | |||
| Net loss attributable to common stockholders | |||
| Net loss per common share, basic and diluted | |||
| Weighted average number of common shares outstanding, basic and diluted |
Loading...